Advanced glycation endproducts (AGEs) as uremic toxins

Publikation: Beitrag in FachzeitschriftÜbersichtsartikel (Review)BeigetragenBegutachtung

Beitragende

  • Universität Heidelberg
  • Technische Universität Dresden

Abstract

Products of non-enzymatic glycation accumulate both in diabetic and non-diabetic patients with renal failure. The increase in concentration is presumably due to increased generation, secondary to oxydative stress and due to decreased (renal) elimination; whether accumulation of AGEs of dietary origin plays a role is currently under investigation. AGE's have been related to progression of diabetic land possibly also non-diabetic) renal disease and to a number of complications of the uremic syndrome. These comprise beta-2-microglobulin-derived dialysis-related amyloidosis, dyslipidemia, vascular dysfunction and accelerated atherogenesis. A specific case is AGE related damage to the peritoneal membrane in CAPD patients. Removal of AGE by dialysis is negligible and even high flux dialysis eliminates only a quantitatively limited amount of AGE. In contrast, a rapid decrease of AGE concentrations in plasma is noted after renal transplantation. Dietary AGEs may contribute significantly to the total AGE load of the body, particularly in uremia.

Details

OriginalspracheEnglisch
Seiten (von - bis)172-176
Seitenumfang5
FachzeitschriftNahrung = Food
Jahrgang45
Ausgabenummer3
PublikationsstatusVeröffentlicht - Juni 2001
Peer-Review-StatusJa

Externe IDs

Scopus 0041735035

Schlagworte

Ziele für nachhaltige Entwicklung

Schlagwörter

  • HEMODIALYSIS-ASSOCIATED AMYLOIDOSIS, DIALYSIS-RELATED AMYLOIDOSIS, GLYCOSYLATION END-PRODUCTS, CHRONIC-RENAL-FAILURE, DIABETIC NEPHROPATHY, IMMUNOHISTOCHEMICAL DETECTION, MAILLARD REACTION, OXIDATIVE STRESS, BONE-RESORPTION, PLASMA